Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Promuc
AddedFeb 18, 2024
UpdatedJun 18, 2026
Promuc

Promuc

Inactive

ProMuc, Inc. creates synthetic mucins for lubrication and antimicrobial uses.

HQ
New York City, NY, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

ProMuc, Inc. was founded with the mission to innovate in the field of synthetic mucins for lubrication and antimicrobial applications. The company envisions a future where synthetic mucins can significantly enhance various industrial and medical processes by providing superior lubrication and antimicrobial properties. ProMuc's core products are designed to cater to industries requiring advanced lubrication solutions and antimicrobial protection, focusing on both efficiency and safety.

ProMuc has garnered attention from notable figures in the biotechnology sector and has secured investments from key players interested in cutting-edge synthetic biology applications. The company has achieved significant milestones, including successful participation in international conferences and collaborations with prestigious institutions across Latin America. ProMuc's impact is evident in its contributions to improving industrial processes and healthcare outcomes through innovative synthetic mucin technology.

Promuc - Similar Companies

MuciMed logo

MuciMed

Mucommune logo

Mucommune

mucommune.com

Promosome logo

Promosome

Petri Bio logo

Petri Bio

petribio.com

Luca Biologics logo

Luca Biologics

seedhealth.com

Microbial Machines logo

Microbial Machines

Biomimedica logo

Biomimedica

biomimedica.com

Poly Group logo

Poly Group

polygroupllc.net

AsimicA logo

AsimicA

asimica.com

Synedgen logo

Synedgen

synedgen.com

Promiliad Biopharma logo

Promiliad Biopharma

Promakhos Therapeutics logo

Promakhos Therapeutics

promakhos.com

PolyLux logo

PolyLux

polylux.co

Carmolex logo

Carmolex

Polybiotics logo

Polybiotics

Promuc - Quick Facts

Who are Promuc's competitors?

Companies similar to Promuc include MuciMed, Mucommune, Promosome and Petri Bio.

When was Promuc founded?

Promuc was founded in 2014.

Where is Promuc's headquarters located?

Promuc's headquarters is located in New York City, NY, US.

When was Promuc's last funding round?

Promuc's most recent funding round was for $350k (USD) in March 2014.

How much has Promuc raised to-date?

As of Mar 4, 2014, Promuc has raised a total of $350k (USD).

Promuc - Classification

NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified